echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > [heavyweight] the pilot program of traditional Chinese medicine formula granules is expected to be released, and relevant traditional Chinese medicine enterprises may benefit from it

    [heavyweight] the pilot program of traditional Chinese medicine formula granules is expected to be released, and relevant traditional Chinese medicine enterprises may benefit from it

    • Last Update: 2015-03-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: great wisdom ashdak news agency, March 10, 2015, the pilot qualification of traditional Chinese medicine formula granules was released again DZH news has learned exclusively from a number of industry insiders that the state will hold a meeting to discuss the release of the pilot qualification of traditional Chinese medicine formula granules The enterprises that can carry out the production of traditional Chinese medicine formula granules will not only be limited to the current six, and relevant enterprises are expected to benefit from this "There is likely to be a timetable for national talks after the two sessions," he said A personage of a Chinese patent medicine enterprise in China disclosed to the big wisdom news agency The chairman of another large Chinese medicine listed company also said that the country has the idea of liberalizing the Chinese medicine formula particles "Some standard requirements may be added, but the number of pilot enterprises will not be limited to those six." Traditional Chinese medicine formula granule is a single traditional Chinese medicine product, which is refined by extraction, concentration, drying and other processes of traditional Chinese medicine decoction with modern science and technology The gross profit level of this product is higher, generally more than 70%, while the gross profit of general Chinese herbal pieces is only about 30% In 2001, the State Food and Drug Administration (CFDA) approved six Chinese medicine enterprises to engage in the production of traditional Chinese medicine formula granules, including China Resources Sanjiu, Jiangyin Tianjiang Pharmaceutical Co., Ltd under Shanghai Jiahua, Beijing kangrentang Pharmaceutical Co., Ltd under HongRi pharmaceutical, etc Among them, 50% of the net profit of HongRi pharmaceutical industry comes from the above business contribution According to the Research Report of securities companies, the market scale of traditional Chinese medicine formula granules was only 228 million in 2006 and 4.2 billion in 2013, with a compound growth rate of 51.6% It is worth mentioning that many traditional Chinese medicine enterprises intend to enter due to the low technical threshold and high profit margin of traditional Chinese medicine formula granules In September 2012, the national pharmacopoeia committee arranged to launch 12 demonstration research on the quality standards of traditional Chinese medicine formula granules; meanwhile, Jilin and Anhui Province also released the qualification of traditional Chinese medicine formula granules pilot enterprises However, in July 2013, CFDA issued a document saying that traditional Chinese medicine formula granules are still in the pilot research, and it is strictly prohibited for each provincial food and drug administration to approve the production of traditional Chinese medicine formula granules by itself It is worth mentioning that relevant enterprises are waiting for the policy to be liberalized There has been a lot of talk about the pilot of liberalizing traditional Chinese medicine formula granules, and a number of Chinese patent medicine enterprises in the industry have arranged in advance in this field as early as a few years ago According to the public data, Kangmei pharmaceutical expanded the automatic production and online quality monitoring technology transformation project of traditional Chinese medicine formula granules in the reserved land of the plant area of phase II project of traditional Chinese medicine decoction pieces People at the company said that the company had been preparing the technology for several years and was ready The essence of pharmaceutical companies, said the company's essence pharmaceutical Bozhou Kang Pu Co., Ltd has a Chinese herbal medicine production workshop, has not heard of the recent policy liberalization Previously, the person had said that the plant would gradually enter the production of traditional Chinese medicine formula granules in the future People from Xiangxue pharmaceutical company also disclosed to big wisdom news agency that the company has the idea of dabbling in traditional Chinese medicine formula granules  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.